Walked home from a clinical study check-in, grateful for an eyewateringly expensive study drug in my daypack. The study, funded by the Department of Defense, promises to save many millions of dollars in cancer care. The contrast with last week’s abrupt shutdown of USAID-funded research feels deeply unjust. Thousands have been left with experimental drugs and devices in their bodies, without access to monitoring or care.
